Mainstreaming the Microbiome
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s […]
General Biotechnology
Which pharmaceutical companies have the most “New Dosage Form” drugs?
New Dosage Forms are one of the categories for which the FDA grants three years of exclusivity for ‘New Clinical
Which pharmaceutical companies have the most “New Dosage Form” drugs? Read Post »
General Biotechnology
Which pharma companies have the most ‘New Dosage Form’ exclusivities?
New Dosage Forms are one of the categories for which the FDA grants three years of exclusivity for ‘New Clinical
Which pharma companies have the most ‘New Dosage Form’ exclusivities? Read Post »
General Biotechnology
Bioentrepreneurship education programmes in the United States
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Bioentrepreneurship education programmes in the United States
Go to paperABSTRACT: In this first paper of a new regular column, Arlen Meyers and Patrick…
Bioentrepreneurship education programmes in the United States Read Post »
General Biotechnology
Legal and regulatory update
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Legal and regulatory update
Go to paperABSTRACT: The Office of Fair Trading (OFT) has recently found Genzyme Limited guilty of abusing its dominant posi…
General Biotechnology
Make in India — nowhere to go but up
Make in India recently published an advertorial in the Washington Post proclaiming that “2016 is India’s Growth Year For Pharma.”
General Biotechnology
Understanding 'science and the public'
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Understanding ‘science and the public’
Go to paperABSTRACT: Public acceptance of the products of biotechnology is an important issue for the industry. T…
General Biotechnology
Festo: The plague continues
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Festo: The plague continues
Go to paperABSTRACT: This paper reviews the law on the doctrine of equivalence and prosecution history estoppel and explores…
General Biotechnology
DrugPatentWatch adds expired patents from 1985 to present
DrugPatentWatch now contains the most complete resources for pharmaceutical drug patents, expired and acrive, both in the United States and
DrugPatentWatch adds expired patents from 1985 to present Read Post »
General Biotechnology
Startup America: What it includes and opportunities for innovators
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Startup America: What it includes and opportunities for innovators
ABSTRACT:
The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.
Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:
- Management
- Policy
- Finance
- Law
- Regulation
- Bioethics
For more information, see the Journal of Commercial Biotechnology website
Startup America: What it includes and opportunities for innovators Read Post »